cyfendus
Generic: Anthrax Vaccine Adsorbed Adjuvanted·Code: AV7909
cyfendus: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Emergent BioSolutions Inc. (EBS) | Approved |
Clinical Trials (1)
A Phase 4 Retrospective Observational Study of CYFENDUS™ Anthrax Vaccine Among Individuals Who Received Post-Exposure Prophylaxis Vaccination During a Bacillus Anthracis Mass Exposure Event
Frequently asked questions
Who is developing cyfendus?
cyfendus is being developed by Emergent BioSolutions Inc..
How many clinical trials involve cyfendus?
BioSniper tracks 1 clinical trial involving cyfendus.
Get deeper analysis on cyfendus
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis